Article 2 Provision of information to prospective donors Member States shall ensure that blood establishments provide prospective donors of blood or blood components with the information set out in Part A of Annex II.
Article 3 Information required from donors Member States shall ensure that upon agreement of willingness to commence the donation of blood or blood components, donors provide the information set out in Part B of Annex II to the blood establishment.
Article 4 Eligibility of donors Blood establishments shall ensure that donors of whole blood and blood components comply with the eligibility criteria set out in Annex III.
Article 5 Storage, transport and distribution conditions for blood and blood components Blood establishments shall ensure that the storage, transport and distribution conditions for blood and blood components comply with the requirements set out in Annex IV.
Article 6 Quality and safety requirements for blood and blood components Blood establishments shall ensure that the quality and safety requirements for blood and blood components comply with the requirements set out in Annex V.
Article 7 Autologous donations 1.
Article 8 Validation Member States shall ensure that all testing and processes referred to in Annexes II to V are validated.
Article 10 Entry into force This Directive shall enter into force on the 20th day following that of its publication in the Official Journal of the European Union.
Article 11 Addressees This Directive is addressed to the Member States.
Done at Brussels, 22 March 2004.
For the Commission David Byrne Member of the Commission (1) OJ L 33, 8.2.2003, p. 30. (2) OJ L 203, 21.7.1998, p. 14.
ANNEX II INFORMATION REQUIREMENTS (as referred to in Articles 2 and 3) PART A Information to be provided to prospective donors of blood or blood components 1.
PART B Information to be obtained from donors by blood establishments at every donation 1.
ANNEX III ELIGIBILITY CRITERIA FOR DONORS OF WHOLE BLOOD AND BLOOD COMPONENTS (as referred to in Article 4) 1.
Haemoglobin levels in donor's blood %gt%TABLE%gt% 1.3.
Permanent deferral criteria for donors of allogeneic donations %gt%TABLE%gt% 2.2.
Other temporary deferrals %gt%TABLE%gt% 2.3.
Deferral for particular epidemiological situations %gt%TABLE%gt% 2.4.
Deferral criteria for donors of autologous donations %gt%TABLE%gt% ANNEX IV STORAGE, TRANSPORT AND DISTRIBUTION CONDITIONS FOR BLOOD AND BLOOD COMPONENTS (as referred to in Article 5) 1.
Liquid storage %gt%TABLE%gt% 1.2.
Cryopreservation %gt%TABLE%gt% 2.
Autologous blood and blood components must be clearly identified as such and stored, transported and distributed separately from allogeneic blood and blood components. 3.2.
ANNEX V QUALITY AND SAFETY REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS (as referred to in Article 6) 1.
THE BLOOD COMPONENTS %gt%TABLE%gt% 2.
